FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080641912> ?p ?o ?g. }

• W2080641912 endingPage "411" @default.
• W2080641912 startingPage "407" @default.
• W2080641912 abstract "It is well known that chronic atrial fibrillation (CAF) and paroxysmal atrial fibrillation (PAF) are associated with hypercoagulable state. However, pathological hemostatic changes during the paroxysmal supraventricular tachycardia (PSVT) have not yet been elucidated. To determine platelet activity in patients with PSVT, PAF and CAF, we examined the levels of beta-thromboglobulin (BTG) and platelet factor 4 (PF4) during tachyarrhythmia attacks. We measured the levels of BTG and PF4, as an index of platelet activation in 15 patients with PAF (9 men, mean age 45+/-11), and 14 patients with PSVT (8 men, mean age 40+/-10). Levels were compared to 22 age and sex matched healthy controls in sinus rhythm and with 25 patients with CAF (16 men, mean age 51+/-12). Blood samples were taken during arrhythmia and 24 hours after conversion to sinus rhythm. Patients taking medications or have clinical conditions that may affect the BTG and PF4 levels were excluded. In patients with PAF, BTG and PF4 levels were significantly higher than in controls (p<0.009, and p=0.002, respectively), and in patients with PSVT (p<0.004, and p=0.009, respectively), however, BTG and PF4 levels were significantly lower than CAF patients (p=0.002, and p=0.02, respectively). Moreover, BTG and PF4 levels were significantly decreased 24 hours after conversion to sinus rhythm (p<0.0001), and p=0.004, respectively). Although BTG and PF4 levels in patients with PSVT were significantly lower than in patients with PAF (p=0.04, and p=0.009, respectively) and CAF (p=0.0001, and p=0.0001, respectively), BTG and PF4 levels were similar to controls and did not change significantly after recovery to sinus rhythm (p=NS for all). These results indicate that there was no platelet activation in patients with PSVT during tachyarrhythmia but significantly increased platelet activity in PAF and CAF patients. There was a significant decrement of the platelet activity to a level of control subjects twenty-four hours after cardioversion of PAF." @default.
• W2080641912 created "2016-06-24" @default.
• W2080641912 creator A5001647332 @default.
• W2080641912 creator A5006551829 @default.
• W2080641912 creator A5007701278 @default.
• W2080641912 creator A5018822466 @default.
• W2080641912 creator A5025677528 @default.
• W2080641912 creator A5028582261 @default.
• W2080641912 creator A5038658131 @default.
• W2080641912 creator A5040312725 @default.
• W2080641912 creator A5041136544 @default.
• W2080641912 creator A5045012952 @default.
• W2080641912 creator A5070096147 @default.
• W2080641912 creator A5091120575 @default.
• W2080641912 date "2003-11-01" @default.
• W2080641912 modified "2023-10-18" @default.
• W2080641912 title "Patients with paroxysmal atrial fibrillation but not paroxysmal supraventricular tachycardia display evidence of platelet activation during arrhythmia" @default.
• W2080641912 cites W1974001859 @default.
• W2080641912 cites W1977520641 @default.
• W2080641912 cites W1982346511 @default.
• W2080641912 cites W1996712647 @default.
• W2080641912 cites W1997526680 @default.
• W2080641912 cites W2004745920 @default.
• W2080641912 cites W2014913089 @default.
• W2080641912 cites W2036284239 @default.
• W2080641912 cites W2036803032 @default.
• W2080641912 cites W2045452389 @default.
• W2080641912 cites W2052353635 @default.
• W2080641912 cites W2056798392 @default.
• W2080641912 cites W2078573963 @default.
• W2080641912 cites W2078886847 @default.
• W2080641912 cites W2087614414 @default.
• W2080641912 cites W2087673528 @default.
• W2080641912 cites W2094429145 @default.
• W2080641912 cites W2114775432 @default.
• W2080641912 cites W2122730741 @default.
• W2080641912 cites W2144076372 @default.
• W2080641912 cites W4245449645 @default.
• W2080641912 doi "https://doi.org/10.1080/09537100310001638814" @default.
• W2080641912 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14713509" @default.
• W2080641912 hasPublicationYear "2003" @default.
• W2080641912 type Work @default.
• W2080641912 sameAs 2080641912 @default.
• W2080641912 citedByCount "21" @default.
• W2080641912 countsByYear W20806419122012 @default.
• W2080641912 countsByYear W20806419122013 @default.
• W2080641912 countsByYear W20806419122014 @default.
• W2080641912 countsByYear W20806419122015 @default.
• W2080641912 countsByYear W20806419122016 @default.
• W2080641912 countsByYear W20806419122017 @default.
• W2080641912 countsByYear W20806419122018 @default.
• W2080641912 crossrefType "journal-article" @default.
• W2080641912 hasAuthorship W2080641912A5001647332 @default.
• W2080641912 hasAuthorship W2080641912A5006551829 @default.
• W2080641912 hasAuthorship W2080641912A5007701278 @default.
• W2080641912 hasAuthorship W2080641912A5018822466 @default.
• W2080641912 hasAuthorship W2080641912A5025677528 @default.
• W2080641912 hasAuthorship W2080641912A5028582261 @default.
• W2080641912 hasAuthorship W2080641912A5038658131 @default.
• W2080641912 hasAuthorship W2080641912A5040312725 @default.
• W2080641912 hasAuthorship W2080641912A5041136544 @default.
• W2080641912 hasAuthorship W2080641912A5045012952 @default.
• W2080641912 hasAuthorship W2080641912A5070096147 @default.
• W2080641912 hasAuthorship W2080641912A5091120575 @default.
• W2080641912 hasConcept C126322002 @default.
• W2080641912 hasConcept C164705383 @default.
• W2080641912 hasConcept C2775914520 @default.
• W2080641912 hasConcept C2777204175 @default.
• W2080641912 hasConcept C2779161974 @default.
• W2080641912 hasConcept C2780283014 @default.
• W2080641912 hasConcept C2781318281 @default.
• W2080641912 hasConcept C2910597771 @default.
• W2080641912 hasConcept C2985986913 @default.
• W2080641912 hasConcept C3018697912 @default.
• W2080641912 hasConcept C42219234 @default.
• W2080641912 hasConcept C71924100 @default.
• W2080641912 hasConcept C89560881 @default.
• W2080641912 hasConceptScore W2080641912C126322002 @default.
• W2080641912 hasConceptScore W2080641912C164705383 @default.
• W2080641912 hasConceptScore W2080641912C2775914520 @default.
• W2080641912 hasConceptScore W2080641912C2777204175 @default.
• W2080641912 hasConceptScore W2080641912C2779161974 @default.
• W2080641912 hasConceptScore W2080641912C2780283014 @default.
• W2080641912 hasConceptScore W2080641912C2781318281 @default.
• W2080641912 hasConceptScore W2080641912C2910597771 @default.
• W2080641912 hasConceptScore W2080641912C2985986913 @default.
• W2080641912 hasConceptScore W2080641912C3018697912 @default.
• W2080641912 hasConceptScore W2080641912C42219234 @default.
• W2080641912 hasConceptScore W2080641912C71924100 @default.
• W2080641912 hasConceptScore W2080641912C89560881 @default.
• W2080641912 hasIssue "7-8" @default.
• W2080641912 hasLocation W20806419121 @default.
• W2080641912 hasLocation W20806419122 @default.
• W2080641912 hasOpenAccess W2080641912 @default.
• W2080641912 hasPrimaryLocation W20806419121 @default.
• W2080641912 hasRelatedWork W1973573059 @default.
• W2080641912 hasRelatedWork W1974061424 @default.
• W2080641912 hasRelatedWork W1978291450 @default.

• next